Edition:
United States

Sinclair Pharma PLC (SPH.L)

SPH.L on London Stock Exchange

33.50GBp
18 Jan 2017
Change (% chg)

-0.62p (-1.83%)
Prev Close
34.12p
Open
33.50p
Day's High
34.00p
Day's Low
32.75p
Volume
441,669
Avg. Vol
798,253
52-wk High
40.00p
52-wk Low
26.00p

SPH.L

Chart for SPH.L

About

Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and... (more)

Overall

Beta: 0.07
Market Cap(Mil.): £171.38
Shares Outstanding(Mil.): 502.20
Dividend: --
Yield (%): --

Financials

  SPH.L Industry Sector
P/E (TTM): -- 29.57 30.46
EPS (TTM): -0.05 -- --
ROI: -12.56 15.39 14.82
ROE: -23.37 16.58 16.24

BRIEF-Sinclair Pharma FY revenue grows 51 pct

* 12 month revenue to Dec. 31 2016 at 37.8 mln stg, growth of 51 pct*

Jan 17 2017

BRIEF-Sinclair Pharma on track to meet 2016 sales guidance

* Group revenues increased 125 pct to £17.3 million compared to 7.7 million stg in previous six month period

Sep 21 2016

BRIEF-Sinclair Pharma says Christophe Foucher has stepped down from board

* Christophe foucher, chief operating officer, has stepped down from board with immediate effect Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

Sep 01 2016

BRIEF-Sinclair Pharma says second interim period revenues of 17.2 mln stg

* In second interim period, sinclair increased revenues to £17.2m, compared to £7.7m in first interim period

Jul 19 2016

Earnings vs. Estimates